<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-16T11:18:56.5476+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://ascendispharma.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:asnd="http://ascendispharma.com/20221231" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022"/>
  <xsd:import schemaLocation="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd" namespace="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asnd-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asnd-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asnd-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asnd-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/CoverPage" id="CoverPage">
        <link:definition>100000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome" id="ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome">
        <link:definition>100010 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeParenthetical" id="ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeParenthetical">
        <link:definition>100020 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome2" id="StatementConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome2">
        <link:definition>100030 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ConsolidatedStatementsOfFinancialPosition" id="ConsolidatedStatementsOfFinancialPosition">
        <link:definition>100040 - Statement - Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>100050 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ConsolidatedCashFlowStatements" id="ConsolidatedCashFlowStatements">
        <link:definition>100060 - Statement - Consolidated Cash Flow Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/GeneralInformation" id="GeneralInformation">
        <link:definition>100070 - Disclosure - General Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SignificantAccountingJudgementsAndEstimates" id="SignificantAccountingJudgementsAndEstimates">
        <link:definition>100090 - Disclosure - Significant Accounting Judgements and Estimates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/Revenue" id="Revenue">
        <link:definition>100100 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SegmentInformation" id="SegmentInformation">
        <link:definition>100110 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/EmployeeCosts" id="EmployeeCosts">
        <link:definition>100120 - Disclosure - Employee costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPayment" id="ShareBasedPayment">
        <link:definition>100130 - Disclosure - Share-based Payment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PrincipalAccountantFeesAndServices" id="PrincipalAccountantFeesAndServices">
        <link:definition>100140 - Disclosure - Principal Accountant Fees and Services</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/TaxOnProfitLossForTheYearAndDeferredTax" id="TaxOnProfitLossForTheYearAndDeferredTax">
        <link:definition>100150 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>100160 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
        <link:definition>100170 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentInAssociate" id="InvestmentInAssociate">
        <link:definition>100180 - Disclosure - Investment in Associate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/Inventories" id="Inventories">
        <link:definition>100190 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/Leases" id="Leases">
        <link:definition>100200 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ContractLiabilities" id="ContractLiabilities">
        <link:definition>100210 - Disclosure - Contract liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilities1" id="DisclosureFinancialAssetsAndFinancialLiabilities1">
        <link:definition>100220 - Disclosure - Financial Assets and Financial Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>100230 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagement" id="DisclosureFinancialRiskManagement">
        <link:definition>100240 - Disclosure - Financial Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>100250 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentsInGroupEnterprises" id="InvestmentsInGroupEnterprises">
        <link:definition>100260 - Disclosure - Investments in Group Enterprises</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/Ownership" id="Ownership">
        <link:definition>100270 - Disclosure - Ownership</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>100280 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100290 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100300 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/RevenueTables" id="RevenueTables">
        <link:definition>100310 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SegmentInformationTables" id="SegmentInformationTables">
        <link:definition>100320 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureEmployeeCostsTables" id="DisclosureEmployeeCostsTables">
        <link:definition>100330 - Disclosure - Employee Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentTables" id="ShareBasedPaymentTables">
        <link:definition>100340 - Disclosure - Share-based Payment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PrincipalAccountantFeesAndServicesTables" id="PrincipalAccountantFeesAndServicesTables">
        <link:definition>100350 - Disclosure - Principal Accountant Fees and Services (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/TaxOnProfitLossForTheYearAndDeferredTaxTables" id="TaxOnProfitLossForTheYearAndDeferredTaxTables">
        <link:definition>100360 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
        <link:definition>100370 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PropertyPlantAndEquipmentTables" id="PropertyPlantAndEquipmentTables">
        <link:definition>100380 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentInAssociateTables" id="InvestmentInAssociateTables">
        <link:definition>100390 - Disclosure - Investment in Associate (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InventoriesTables" id="InventoriesTables">
        <link:definition>100400 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesTables" id="DisclosureFinancialAssetsAndFinancialLiabilitiesTables">
        <link:definition>100410 - Disclosure - Financial Assets and Financial Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementTables" id="DisclosureFinancialRiskManagementTables">
        <link:definition>100420 - Disclosure - Financial Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentsInGroupEnterprisesTables" id="InvestmentsInGroupEnterprisesTables">
        <link:definition>100430 - Disclosure - Investments in Group Enterprises (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100440 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SummaryOfSignificantAccountingPoliciesScheduleOfAssetsExpectedUsefulLifeDetail" id="SummaryOfSignificantAccountingPoliciesScheduleOfAssetsExpectedUsefulLifeDetail">
        <link:definition>100450 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset's Expected Useful Life (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SignificantAccountingJudgementsAndEstimatesAdditionalInformationDetail" id="SignificantAccountingJudgementsAndEstimatesAdditionalInformationDetail">
        <link:definition>100460 - Disclosure - Significant Accounting Judgements and Estimates - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossDetail" id="RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossDetail">
        <link:definition>100470 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossParentheticalDetail" id="RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossParentheticalDetail">
        <link:definition>100480 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SegmentInformationAdditionalInformationDetail" id="SegmentInformationAdditionalInformationDetail">
        <link:definition>100490 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/SegmentInformationSummaryOfIntangibleAssetsAndPropertyPlantAndEquipmentDetail" id="SegmentInformationSummaryOfIntangibleAssetsAndPropertyPlantAndEquipmentDetail">
        <link:definition>100500 - Disclosure - Segment Information - Summary of Intangible Assets, and Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureEmployeeCostsSummaryOfEmployeeCostDetail" id="DisclosureEmployeeCostsSummaryOfEmployeeCostDetail">
        <link:definition>100510 - Disclosure - Employee Costs - Summary of Employee Cost (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureEmployeeCostsAdditionalInformationDetail" id="DisclosureEmployeeCostsAdditionalInformationDetail">
        <link:definition>100520 - Disclosure - Employee Costs - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentAdditionalInformationDetail" id="ShareBasedPaymentAdditionalInformationDetail">
        <link:definition>100530 - Disclosure - Share-Based Payment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentSummaryOfShareBasedPaymentDetail" id="ShareBasedPaymentSummaryOfShareBasedPaymentDetail">
        <link:definition>100540 - Disclosure - Share-Based Payment - Summary Of Share Based Payment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentScheduleOfWarrantActivityDetail" id="ShareBasedPaymentScheduleOfWarrantActivityDetail">
        <link:definition>100550 - Disclosure - Share-based Payment - Schedule of Warrant Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentScheduleOfWarrantActivityParentheticalDetail" id="ShareBasedPaymentScheduleOfWarrantActivityParentheticalDetail">
        <link:definition>100560 - Disclosure - Share-based Payment  - Schedule of Warrant Activity (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentScheduleOfWeightedAverageExercisePriceAndWeightedRemainingContractualLifeForOutstandingWarrantsDetail" id="ShareBasedPaymentScheduleOfWeightedAverageExercisePriceAndWeightedRemainingContractualLifeForOutstandingWarrantsDetail">
        <link:definition>100570 - Disclosure - Share-based Payment - Schedule of Weighted Average Exercise Price and Weighted Remaining Contractual Life for Outstanding Warrants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ShareBasedPaymentSummaryOfFairValuesForWarrantGrantsDetail" id="ShareBasedPaymentSummaryOfFairValuesForWarrantGrantsDetail">
        <link:definition>100580 - Disclosure - Share-based Payment  - Summary of Fair Values for Warrant Grants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PrincipalAccountantFeesAndServicesSummaryOfPrincipalAccountantFeesAndServicesDetails" id="PrincipalAccountantFeesAndServicesSummaryOfPrincipalAccountantFeesAndServicesDetails">
        <link:definition>100590 - Disclosure - Principal Accountant Fees and Services - Summary of Principal Accountant Fees and Services (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxDetail">
        <link:definition>100600 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxParentheticalDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxParentheticalDetail">
        <link:definition>100610 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/TaxOnProfitLossForTheYearAndDeferredTaxAdditionalInformationDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxAdditionalInformationDetail">
        <link:definition>100620 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/IntangibleAssetsSummaryOfGoodwillDetail" id="IntangibleAssetsSummaryOfGoodwillDetail">
        <link:definition>100630 - Disclosure - Intangible Assets - Summary of Goodwill (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" id="PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail">
        <link:definition>100640 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PropertyPlantAndEquipmentAdditionalInformationDetail" id="PropertyPlantAndEquipmentAdditionalInformationDetail">
        <link:definition>100650 - Disclosure - Property, Plant and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/PropertyPlantAndEquipmentSummaryOfDepreciationsChargesDetail" id="PropertyPlantAndEquipmentSummaryOfDepreciationsChargesDetail">
        <link:definition>100660 - Disclosure - Property, Plant and Equipment - Summary of Depreciations Charges (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentInAssociateAdditionalInformationDetail" id="InvestmentInAssociateAdditionalInformationDetail">
        <link:definition>100670 - Disclosure - Investment in Associate - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentInAssociateScheduleOfFinancialInformationOfInvestmentInVisenDetail" id="InvestmentInAssociateScheduleOfFinancialInformationOfInvestmentInVisenDetail">
        <link:definition>100680 - Disclosure - Investment in Associate - Schedule of Financial Information of Investment in VISEN (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentInAssociateEquityDetail" id="InvestmentInAssociateEquityDetail">
        <link:definition>100690 - Disclosure - Investment in Associate - Equity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InventoriesSummaryOfInventoriesExplanatoryDetail" id="InventoriesSummaryOfInventoriesExplanatoryDetail">
        <link:definition>100700 - Disclosure - Inventories - Summary of Inventories Explanatory (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
        <link:definition>100710 - Disclosure - Leases - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/LeasesSummaryOfDevelopmentInLeaseLiabilitiesDetail" id="LeasesSummaryOfDevelopmentInLeaseLiabilitiesDetail">
        <link:definition>100720 - Disclosure - Leases - Summary of Development In Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/LeasesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail" id="LeasesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail">
        <link:definition>100730 - Disclosure - Leases - Summary of Expenses, Relating To Lease Activities In The Consolidated Statements (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/ContractLiabilitiesAdditionalInformationDetail" id="ContractLiabilitiesAdditionalInformationDetail">
        <link:definition>100740 - Disclosure - Contract Liabilities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesAdditionalInformationDetail" id="DisclosureFinancialAssetsAndFinancialLiabilitiesAdditionalInformationDetail">
        <link:definition>100750 - Disclosure - Financial Assets and Financial Liabilities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesScheduleOfFinancialAssetsAndFinancialLiabilitiesDetail" id="DisclosureFinancialAssetsAndFinancialLiabilitiesScheduleOfFinancialAssetsAndFinancialLiabilitiesDetail">
        <link:definition>100760 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Financial assets and Financial Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesScheduleOfFinanceIncomeAndFinanceExpensesDetail" id="DisclosureFinancialAssetsAndFinancialLiabilitiesScheduleOfFinanceIncomeAndFinanceExpensesDetail">
        <link:definition>100770 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Finance Income and Finance Expenses (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail" id="DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail">
        <link:definition>100780 - Disclosure - Financial Assets and Financial Liabilities - Summary of Expenses, Relating To Lease Activities In The Consolidated Statements (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfDevelopmentInBorrowingsArisingFromFinancingActivitiesDetails" id="DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfDevelopmentInBorrowingsArisingFromFinancingActivitiesDetails">
        <link:definition>100790 - Disclosure - Financial Assets and Financial Liabilities - Summary of Development in Borrowings Arising from Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfFairValueHierarchyDetails" id="DisclosureFinancialAssetsAndFinancialLiabilitiesSummaryOfFairValueHierarchyDetails">
        <link:definition>100800 - Disclosure - Financial Assets and Financial Liabilities - Summary of Fair Value Hierarchy (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialAssetsAndFinancialLiabilitiesMovementsInLevel3FairValueMeasurementsDetails" id="DisclosureFinancialAssetsAndFinancialLiabilitiesMovementsInLevel3FairValueMeasurementsDetails">
        <link:definition>100810 - Disclosure - Financial Assets and Financial Liabilities - Movements in Level 3 Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementSummaryOfNumberOfSharesDetail" id="DisclosureFinancialRiskManagementSummaryOfNumberOfSharesDetail">
        <link:definition>100820 - Disclosure - Financial Risk Management - Summary of Number of Shares (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementAdditionalInformationDetail" id="DisclosureFinancialRiskManagementAdditionalInformationDetail">
        <link:definition>100830 - Disclosure - Financial Risk Management - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementSummaryOfHoldingOfTreasurySharesDetail" id="DisclosureFinancialRiskManagementSummaryOfHoldingOfTreasurySharesDetail">
        <link:definition>100840 - Disclosure - Financial Risk Management - Summary of Holding of Treasury Shares (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementScheduleOfForeignCurrencySensitivityAnalysisDetail" id="DisclosureFinancialRiskManagementScheduleOfForeignCurrencySensitivityAnalysisDetail">
        <link:definition>100850 - Disclosure - Financial Risk Management - Schedule of Foreign Currency Sensitivity Analysis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementSummaryOfRateStructureOfMarketableSecuritiesDetail" id="DisclosureFinancialRiskManagementSummaryOfRateStructureOfMarketableSecuritiesDetail">
        <link:definition>100860 - Disclosure - Financial Risk Management - Summary of Rate Structure of Marketable Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementScheduleOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingDetail" id="DisclosureFinancialRiskManagementScheduleOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingDetail">
        <link:definition>100870 - Disclosure - Financial Risk Management - Schedule of Marketable Securities Specified By Investment Grade Credit Rating (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementSummaryOfMarketableSecuritiesDetail" id="DisclosureFinancialRiskManagementSummaryOfMarketableSecuritiesDetail">
        <link:definition>100880 - Disclosure - Financial Risk Management - Summary of Marketable securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/DisclosureFinancialRiskManagementSummaryOfContractualCashflowsForFinancialLiabilitiesDetail" id="DisclosureFinancialRiskManagementSummaryOfContractualCashflowsForFinancialLiabilitiesDetail">
        <link:definition>100890 - Disclosure - Financial Risk Management - Summary of Contractual Cashflows for Financial Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>100900 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/InvestmentsInGroupEnterprisesSummaryOfInvestmentsInGroupEnterprisesDetail" id="InvestmentsInGroupEnterprisesSummaryOfInvestmentsInGroupEnterprisesDetail">
        <link:definition>100910 - Disclosure - Investments in Group Enterprises - Summary of Investments in Group Enterprises (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/20221231/taxonomy/role/OwnershipAdditionalInformationDetail" id="OwnershipAdditionalInformationDetail">
        <link:definition>100920 - Disclosure - Ownership - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="asnd_AssociateAbstract" name="AssociateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ChangesInWorkingCapitalAbstract" name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfBeneficialOwnershipAbstract" name="DisclosureOfBeneficialOwnershipAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfEmployeeCompensationCostsAbstract" name="DisclosureOfEmployeeCompensationCostsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfGeneralInformationAbstract" name="DisclosureOfGeneralInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfHoldingOfTreasurySharesAbstract" name="DisclosureOfHoldingOfTreasurySharesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingAbstract" name="DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfSharebasedPaymentArrangementsAbstract" name="DisclosureOfSharebasedPaymentArrangementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" name="DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FinanceExpensesAbstract" name="FinanceExpensesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FinanceIncomeAbstract" name="FinanceIncomeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FinanceIncomeExpenseAbstract" name="FinanceIncomeExpenseAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_InventoriesAbstract" name="InventoriesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_InvestmentsInGroupEnterprisesAbstract" name="InvestmentsInGroupEnterprisesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" name="NonCurrentAssetsFinanceLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ProfitLossBeforeIncomeTaxAbstract" name="ProfitLossBeforeIncomeTaxAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SummaryOfSignificantAccountingPoliciesAbstract" name="SummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_TextBlockAbstract" name="TextBlockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_TransactionsAndOutstandingBalancesAbstract" name="TransactionsAndOutstandingBalancesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AntidilutiveSecuritiesNotIncludedInDilutedEarningsPerShareAxis" name="AntidilutiveSecuritiesNotIncludedInDilutedEarningsPerShareAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CategoriesOfSharesBasedPaymentsAxis" name="CategoriesOfSharesBasedPaymentsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ClassificationOfRelatedPartyAxis" name="ClassificationOfRelatedPartyAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ForeignCurrencyRiskAxis" name="ForeignCurrencyRiskAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FunctionalCurrencyAxis" name="FunctionalCurrencyAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_IncomeStatementAxis" name="IncomeStatementAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_MinimumNumberOfCollaborationPartnerAxis" name="MinimumNumberOfCollaborationPartnerAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ShareBasedPaymentArrangementAwardTypeAxis" name="ShareBasedPaymentArrangementAwardTypeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" name="StatementOfComprehensiveIncomeProfitOrLossLocationAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_VestingOfSharesAxis" name="VestingOfSharesAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AdditionalLeasePeriodInAdditonToNonCancellablePeriod" name="AdditionalLeasePeriodInAdditonToNonCancellablePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_AdditionalTaxDeduction" name="AdditionalTaxDeduction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_AdditionsToLeaseLiabilities" name="AdditionsToLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_AdjustmentsForNonCashConsiderationRegardingRevenue" name="AdjustmentsForNonCashConsiderationRegardingRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_BasicAndDilutedEarningsLossPerShares" name="BasicAndDilutedEarningsLossPerShares" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsConditionForRedemption" name="BorrowingsConditionForRedemption" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsInArrearsDefaultPaymentStartDate" name="BorrowingsInArrearsDefaultPaymentStartDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsRedemptionPeriod" name="BorrowingsRedemptionPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsThresholdConsecutiveTradingDaysForRedemption" name="BorrowingsThresholdConsecutiveTradingDaysForRedemption" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsThresholdPercentageOfSalePricePerShareForRedemption" name="BorrowingsThresholdPercentageOfSalePricePerShareForRedemption" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_BorrowingsThresholdTradingDaysForRedemption" name="BorrowingsThresholdTradingDaysForRedemption" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ConstructionExpenditureIncurredButNotPaid" name="ConstructionExpenditureIncurredButNotPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_ContractualUndiscountedCashflowOfBorrowings" name="ContractualUndiscountedCashflowOfBorrowings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ContractualUndiscountedCashflowOfConvertibleSeniorNotes" name="ContractualUndiscountedCashflowOfConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ContractualUndiscountedCashflowOfFinancialLeaseLiabilities" name="ContractualUndiscountedCashflowOfFinancialLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ContractualUndiscountedCashflowOfFinancialLiabilities" name="ContractualUndiscountedCashflowOfFinancialLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ContractualUndiscountedCashflowOfTradePayablesAndOtherPayables" name="ContractualUndiscountedCashflowOfTradePayablesAndOtherPayables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ConversionPricePerShare" name="ConversionPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ConversionRatePerNote" name="ConversionRatePerNote" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ConvertibleSeniorNotes" name="ConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_CostsOfCapitalIncreaseDecrease" name="CostsOfCapitalIncreaseDecrease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_DeferredRevenueFromAssociate" name="DeferredRevenueFromAssociate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_DeferredTaxAssetNotRecognized" name="DeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_DerivativeFinancialLiabilitiesAtFairValueRemeasurementRecognizedInFinancialIncomeOrExpense" name="DerivativeFinancialLiabilitiesAtFairValueRemeasurementRecognizedInFinancialIncomeOrExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_DescriptionsOfRiskFreeInterestRateShareOptionsGranted" name="DescriptionsOfRiskFreeInterestRateShareOptionsGranted" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DistributableEquity" name="DistributableEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_EliminationOfInternalProfitRecognized" name="EliminationOfInternalProfitRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_EnforceableLeaseterm" name="EnforceableLeaseterm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ExpectedLeaseCommenceYear" name="ExpectedLeaseCommenceYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_FairValueOfWarrantsGranted" name="FairValueOfWarrantsGranted" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ForeignCurrencyTargetPercentage" name="ForeignCurrencyTargetPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_GoodwillAndOtherIntangibleAssets" name="GoodwillAndOtherIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_IncreaseDecreaseInDerivativeFinancialLiabilitiesFairValue" name="IncreaseDecreaseInDerivativeFinancialLiabilitiesFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_IncreaseDecreaseInForeignCurrencyExchangeRate" name="IncreaseDecreaseInForeignCurrencyExchangeRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_IncreaseDecreaseInTreasurySharesAcquiredFromThirdParties" name="IncreaseDecreaseInTreasurySharesAcquiredFromThirdParties" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_IncreaseDecreaseInTreasurySharesTransferredUnderStockIncentiveProgram" name="IncreaseDecreaseInTreasurySharesTransferredUnderStockIncentiveProgram" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_IncreaseDecreaseThroughCashContribution" name="IncreaseDecreaseThroughCashContribution" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_IncreaseDecreaseThroughEffectOfAccretionOfInterestLiabilitiesArisingFromFinancingActivities" name="IncreaseDecreaseThroughEffectOfAccretionOfInterestLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_IncreaseDecreaseThroughEffectOfProceedsLiabilitiesArisingFromFinancingActivities" name="IncreaseDecreaseThroughEffectOfProceedsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_IncreaseDecreaseThroughEffectOfRepaymentsLiabilitiesArisingFromFinancingActivities" name="IncreaseDecreaseThroughEffectOfRepaymentsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_LeaseCommencePeriod" name="LeaseCommencePeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_LeaseExpenses" name="LeaseExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_LeaseExtensionPeriod" name="LeaseExtensionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_LeaseTerm" name="LeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_MajorPersonsOrGroupsOfAffiliatedPersonsHoldingMinimumBeneficialOwnership" name="MajorPersonsOrGroupsOfAffiliatedPersonsHoldingMinimumBeneficialOwnership" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_MarketableSecuritiesExplanatory" name="MarketableSecuritiesExplanatory" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_MinimumBeneficialOwnershipPercentage" name="MinimumBeneficialOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NetProceedsFromConvertibleSeniorNotes" name="NetProceedsFromConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_NominalValueAmount" name="NominalValueAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_NumberOfAdditionalSharesGranted" name="NumberOfAdditionalSharesGranted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfEmployees1" name="NumberOfEmployees1" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfLicenses" name="NumberOfLicenses" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfOtherEquityInstrumentsSettledInShareBasedPaymentArrangement" name="NumberOfOtherEquityInstrumentsSettledInShareBasedPaymentArrangement" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfOtherEquityInstrumentsTransferredInShareBasedPaymentArrangement" name="NumberOfOtherEquityInstrumentsTransferredInShareBasedPaymentArrangement" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" name="NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfReportableOperatingSegments" name="NumberOfReportableOperatingSegments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_NumberOfTreasurySharesOutstanding" name="NumberOfTreasurySharesOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_OtherTemporaryDifferencesBeforeValuationAllowances" name="OtherTemporaryDifferencesBeforeValuationAllowances" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_PercentageOfWarrantsVested" name="PercentageOfWarrantsVested" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_PotentialConversionOfConvertibleSeniorNotesIntoNumberOfOrdinaryShares" name="PotentialConversionOfConvertibleSeniorNotesIntoNumberOfOrdinaryShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ProfitLossForTheYear" name="ProfitLossForTheYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ProjectCostAccrualsCurrent" name="ProjectCostAccrualsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ProjectCostPrepaymentsCurrent" name="ProjectCostPrepaymentsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_PurchaseOfTreasurySharesNominalValue" name="PurchaseOfTreasurySharesNominalValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_RealizedDurationOfFinancialAssetsExplanatory" name="RealizedDurationOfFinancialAssetsExplanatory" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ReimbursementFromAcquisitionOfPropertyPlantAndEquipment" name="ReimbursementFromAcquisitionOfPropertyPlantAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_ReserveOfTreasuryShares" name="ReserveOfTreasuryShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_RevenueFromSaleOfClinicalSupply" name="RevenueFromSaleOfClinicalSupply" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_Revenuerecognizedfromcontractliabilities" name="Revenuerecognizedfromcontractliabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_ReversalOfGainLossOnPropertyPlantAndEquipment" name="ReversalOfGainLossOnPropertyPlantAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_SaleOfGoodsAndServicesToAssociate" name="SaleOfGoodsAndServicesToAssociate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_SharebasedPaymentArrangementVestingPeriod" name="SharebasedPaymentArrangementVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ShareOfEquityAfterEliminations" name="ShareOfEquityAfterEliminations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_ShareOfEquityBeforeEliminations" name="ShareOfEquityBeforeEliminations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_SharePriceAppliedForValuation" name="SharePriceAppliedForValuation" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_ShareRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" name="ShareRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_TaxEffectFromDeferredTaxAssetNotRecognized" name="TaxEffectFromDeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_TaxEffectOfDeductibleItemsNotExpensed" name="TaxEffectOfDeductibleItemsNotExpensed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asnd_TaxEffectsFromImpactsFromAssociates" name="TaxEffectsFromImpactsFromAssociates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_TaxLossesCarryforwards" name="TaxLossesCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_TreasurySharesHoldingInPercentageOfTotalOutstandingShares" name="TreasurySharesHoldingInPercentageOfTotalOutstandingShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_TreasurySharesHoldingInPercentageOfTotalOutstandingSharesAcquiredFromThirdParties" name="TreasurySharesHoldingInPercentageOfTotalOutstandingSharesAcquiredFromThirdParties" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_TreasurySharesHoldingInPercentageTransferredUnderStockIncentivePrograms" name="TreasurySharesHoldingInPercentageTransferredUnderStockIncentivePrograms" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_TreasurySharesTransferredUnderStockIncentiveProgramNominalValue" name="TreasurySharesTransferredUnderStockIncentiveProgramNominalValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_UtilisationOfInventoryWriteDowns" name="UtilisationOfInventoryWriteDowns" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_WarrantCompensationCost" name="WarrantCompensationCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asnd_WeightedAverageDurationOfMarketableSecuritiesCurrentExplanatory" name="WeightedAverageDurationOfMarketableSecuritiesCurrentExplanatory" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_WeightedAverageDurationOfMarketableSecuritiesExplanatory" name="WeightedAverageDurationOfMarketableSecuritiesExplanatory" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrentExplanatory" name="WeightedAverageDurationOfMarketableSecuritiesNoncurrentExplanatory" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" name="WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asnd_WeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstruments" name="WeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstruments" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_YearOfGrantOfWarrants" name="YearOfGrantOfWarrants" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_CategoriesOfSharesBasedPaymentsDomain" name="CategoriesOfSharesBasedPaymentsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ClassificationOfRelatedPartyDomain" name="ClassificationOfRelatedPartyDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ForeignCurrencyRiskDomain" name="ForeignCurrencyRiskDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FunctionalCurrencyDomain" name="FunctionalCurrencyDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_IncomeStatementDomain" name="IncomeStatementDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SharebasedPaymentArrangementAwardTypeDomain" name="SharebasedPaymentArrangementAwardTypeDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ContractLiabilitiesLineItems" name="ContractLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" name="DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfAssociateLineItems" name="DisclosureOfAssociateLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfAssociatesAndJointVenturesLineItems" name="DisclosureOfAssociatesAndJointVenturesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfBeneficialOwnershipLineItems" name="DisclosureOfBeneficialOwnershipLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfCommitmentsAndContingenciesLineItems" name="DisclosureOfCommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfDetailedInformationAboutDepreciationsChargesLineItems" name="DisclosureOfDetailedInformationAboutDepreciationsChargesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfEmployeeCompensationCostsLineItems" name="DisclosureOfEmployeeCompensationCostsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfHoldingOfTreasurySharesLineItems" name="DisclosureOfHoldingOfTreasurySharesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingLineItems" name="DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" name="DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfWarrantActivityLineItems" name="DisclosureOfWarrantActivityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SharebasedPaymentArrangementRestrictedStockUnitActivityLineItems" name="SharebasedPaymentArrangementRestrictedStockUnitActivityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SummaryOfInventoryDisclosureLineItems" name="SummaryOfInventoryDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AcquisitionOfPropertyPlantAndEquipmentMember" name="AcquisitionOfPropertyPlantAndEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AdditionalOfficeFacilityMember" name="AdditionalOfficeFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AgencyBondsMember" name="AgencyBondsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AmericanDepositarySharesMember" name="AmericanDepositarySharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AmericanDepositorySharesMember" name="AmericanDepositorySharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AntidilutiveSecuritiesNotIncludedInDilutedEarningsPerShareMember" name="AntidilutiveSecuritiesNotIncludedInDilutedEarningsPerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaBoneDiseaseASMember" name="AscendisPharmaBoneDiseaseASMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaEndocrinologyDivisionASMember" name="AscendisPharmaEndocrinologyDivisionASMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaEndocrinologyGmbhMember" name="AscendisPharmaEndocrinologyGmbhMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaEndocrinologyIncMember" name="AscendisPharmaEndocrinologyIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaGmbHMember" name="AscendisPharmaGmbHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaGrowthDisordersASMember" name="AscendisPharmaGrowthDisordersASMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaIncMember" name="AscendisPharmaIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaOncologyDivisionAsMember" name="AscendisPharmaOncologyDivisionAsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_AscendisPharmaOphthalmologyDivisionASMember" name="AscendisPharmaOphthalmologyDivisionASMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_BakerBrosAdvisorsLPMember" name="BakerBrosAdvisorsLPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_BoardMembersOfGroupMember" name="BoardMembersOfGroupMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_BoardOfDirectorsMember" name="BoardOfDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_BritishPoundsToEuroMember" name="BritishPoundsToEuroMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CollaborationPartnerOneMember" name="CollaborationPartnerOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CollaborationPartnersAndLicenseAgreementsMember" name="CollaborationPartnersAndLicenseAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CommercialCustomersMember" name="CommercialCustomersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CommercialPapersMember" name="CommercialPapersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ConvertibleSeniorNotesMember" name="ConvertibleSeniorNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_CorporateBondsMember" name="CorporateBondsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DecemberTwoThousandAndTwentyFourMember" name="DecemberTwoThousandAndTwentyFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DecemberTwoThousandAndTwentyThreeMember" name="DecemberTwoThousandAndTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DecemberTwoThousandAndTwentyTwoMember" name="DecemberTwoThousandAndTwentyTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EntitiesAffiliatedWithArtisanPartnersLimitedPartnershipMember" name="EntitiesAffiliatedWithArtisanPartnersLimitedPartnershipMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EntitiesAffiliatedWithFmrLlcMember" name="EntitiesAffiliatedWithFmrLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EntitiesAffiliatedWithJanusHendersonGroupPlcMember" name="EntitiesAffiliatedWithJanusHendersonGroupPlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EntitiesAffiliatedWithRaCapitalManagementLlcMember" name="EntitiesAffiliatedWithRaCapitalManagementLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EntitiesAffiliatedWithWellingtonManagementGroupLlpMember" name="EntitiesAffiliatedWithWellingtonManagementGroupLlpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_EventsAfterReportingPeriodMember" name="EventsAfterReportingPeriodMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ExecutiveBoardMember" name="ExecutiveBoardMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_FairValueHierarchyCarryingAmountMember" name="FairValueHierarchyCarryingAmountMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ForeignCurrencyConversionOptionMember" name="ForeignCurrencyConversionOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_Germany1Member" name="Germany1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2012To2017Member" name="GrantedIn2012To2017Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2012To2018Member" name="GrantedIn2012To2018Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2018Member" name="GrantedIn2018Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2019Member" name="GrantedIn2019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2020Member" name="GrantedIn2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2021Member" name="GrantedIn2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_GrantedIn2022Member" name="GrantedIn2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_HighGradeMember" name="HighGradeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_LowerMediumGradeMember" name="LowerMediumGradeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_NonexecutiveseniorManagementMember" name="NonexecutiveseniorManagementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_NorthAmerica1Member" name="NorthAmerica1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_OfficeFacilityMember" name="OfficeFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_OtherEquipmentMember" name="OtherEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_PlantAndMachineryMember" name="PlantAndMachineryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_Prime1Member" name="Prime1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ProcessPlantAndMachineryMember" name="ProcessPlantAndMachineryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ResearchAndDevelopmentCostsMember" name="ResearchAndDevelopmentCostsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_RightToUseMember" name="RightToUseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SalesRebatesAndProductReturnsMember" name="SalesRebatesAndProductReturnsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SharePriceMeasurementInputMember" name="SharePriceMeasurementInputMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" name="StatementOfComprehensiveIncomeProfitOrLossLocationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SwissFrancToEuroMember" name="SwissFrancToEuroMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_TRowePriceAssociatesincMember" name="TRowePriceAssociatesincMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_TwoThousandAndTwentyThreeToTwoThousandAndTwentySixMember" name="TwoThousandAndTwentyThreeToTwoThousandAndTwentySixMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_TwoThousandAndTwentyTwoMember" name="TwoThousandAndTwentyTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_UpperMediumGradeMember" name="UpperMediumGradeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_USDollarsMember" name="USDollarsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_UsDollarsToEuroMember" name="UsDollarsToEuroMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_UsGovernmentBondsMember" name="UsGovernmentBondsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_UsTreasuryBillsMember" name="UsTreasuryBillsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_VestingMember" name="VestingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_VISENPharmaceuticalMember" name="VISENPharmaceuticalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_Warrant1Member" name="Warrant1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_WarrantsGranted2012UntilNovember2021Member" name="WarrantsGranted2012UntilNovember2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_WarrantsGrantedFromDecember2021Member" name="WarrantsGrantedFromDecember2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ZeroCouponMember" name="ZeroCouponMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ContractLiabilitiestableTable" name="ContractLiabilitiestableTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" name="DisclosureDetailedInformationAboutMarketableSecuritiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfBeneficialOwnershipTable" name="DisclosureOfBeneficialOwnershipTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfCommitmentsAndContingenciesTable" name="DisclosureOfCommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfDetailedInformationAboutDepreciationsChargesTable" name="DisclosureOfDetailedInformationAboutDepreciationsChargesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfEmployeeCompensationCostsTable" name="DisclosureOfEmployeeCompensationCostsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfHoldingOfTreasurySharesTable" name="DisclosureOfHoldingOfTreasurySharesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingTable" name="DisclosureOfMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" name="DisclosureOfSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SharebasedPaymentArrangementRestrictedStockUnitActivityTable" name="SharebasedPaymentArrangementRestrictedStockUnitActivityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_SummaryOfInventoryDisclosureTable" name="SummaryOfInventoryDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asnd_ContractualCashflowsForFinancialLiabilitiesTextBlock" name="ContractualCashflowsForFinancialLiabilitiesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForAllowanceForExpectedCreditLossesOnFinancialAssetsExplanatory" name="DescriptionOfAccountingPolicyForAllowanceForExpectedCreditLossesOnFinancialAssetsExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesAndDisclosuresExpalanatory" name="DescriptionOfAccountingPolicyForChangesInAccountingPoliciesAndDisclosuresExpalanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForConvertibleNotesAndEmbeddedDerivativeLiabilitiesPolicyTextBlock" name="DescriptionOfAccountingPolicyForConvertibleNotesAndEmbeddedDerivativeLiabilitiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForDeferredRevenuesAndContractLiabilitiesExplanatory" name="DescriptionOfAccountingPolicyForDeferredRevenuesAndContractLiabilitiesExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForDepreciationUnderPropertyPlantAndEquipmentExplanatory" name="DescriptionOfAccountingPolicyForDepreciationUnderPropertyPlantAndEquipmentExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForDilutedEarningsPerShareExplanatory" name="DescriptionOfAccountingPolicyForDilutedEarningsPerShareExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForOtherPayablesExplanatoryTextBlock" name="DescriptionOfAccountingPolicyForOtherPayablesExplanatoryTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForPrepaymentsExplanatory" name="DescriptionOfAccountingPolicyForPrepaymentsExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfAccountingPolicyForStockholdersEquityExplanatory" name="DescriptionOfAccountingPolicyForStockholdersEquityExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfBasisOfConsolidationExplanatory" name="DescriptionOfBasisOfConsolidationExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DescriptionOfConsolidationPrinciplesExplanatory" name="DescriptionOfConsolidationPrinciplesExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTextBlock" name="DisclosureDetailedInformationAboutMarketableSecuritiesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfBeneficialOwnershipExplanatory" name="DisclosureOfBeneficialOwnershipExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfDetailedInformationAboutDepreciationsCharges" name="DisclosureOfDetailedInformationAboutDepreciationsCharges" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfDetailedInformationAboutEmployeeCostExplanatoryTextBlock" name="DisclosureOfDetailedInformationAboutEmployeeCostExplanatoryTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfDetailedInformationForPrincipalAccountantFeesAndServiceExplanatoryTextBlock" name="DisclosureOfDetailedInformationForPrincipalAccountantFeesAndServiceExplanatoryTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfDevelopmentInLeaseLiabilitiesTextBlock" name="DisclosureOfDevelopmentInLeaseLiabilitiesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatements" name="DisclosureOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatements" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" name="DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfFinancialInstrumentsAndFinancialRiskManagementExplanatory" name="DisclosureOfFinancialInstrumentsAndFinancialRiskManagementExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfForeignCurrencySensitivityAnalysisExplanatory" name="DisclosureOfForeignCurrencySensitivityAnalysisExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfInformationAboutMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingExplanatoryTableTextBlock" name="DisclosureOfInformationAboutMarketableSecuritiesSpecifiedByInvestmentGradeCreditRatingExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfMovementsInLevelThreeFairValueMeasurementsTableTextBlock" name="DisclosureOfMovementsInLevelThreeFairValueMeasurementsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstrumentsExplanatory" name="DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstrumentsExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfQuantitativeInformationAboutInventoriesExplanatoryTableTextBlock" name="DisclosureOfQuantitativeInformationAboutInventoriesExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" name="DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_DisclosureOfSummaryOfFairValueHierarchyTableTextBlock" name="DisclosureOfSummaryOfFairValueHierarchyTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asnd_SharebasedPaymentArrangementRestrictedStockUnitActivityTextBlock" name="SharebasedPaymentArrangementRestrictedStockUnitActivityTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
